HIGHLIGHTS
- who: Cassandra L.R. van Doorn from the Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands have published the research: Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment, in the Journal: (JOURNAL)
- what: The aim of this study was to identify a blood transcriptional gene signature to predict TB treatment outcome at an early stage after initiation in a TB population including patients with varying glycaemia and DM status. Data for most variables were not normally distributed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.